Pharmaceutical Technology on MSN8h
FDA CDER director Patrizia Cavazzoni announces resignation
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
ohiocapitaljournal17h
U.S. district judge in opioid proceedings slams pharmacy middlemen, says they’re trying to stall
The U.S. district judge in Cleveland, Ohio handling a galaxy of claims stemming from the prescription opioid epidemic on ...
Royalty Pharma’s Strategic Moves and Share Buyback Plan
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Royalty Pharma simplifies corporate structure with $1.1 bln deal
Royalty Pharma said on Friday it would pay about $1.1 billion to acquire RP Management, an organization that manages the healthcare firm's operations, as it seeks to simplify its corporate structure.
Royalty Pharma Announces Transformative Step In Company’S Evolution With Acquisition Of Its External Manager And $3 Billion Share Repurchase Program
Royalty Pharma plc to become an integrated company by acquiring its external manager, RP Management, LLC <li /> <str ...
Royalty Pharma to Simplify Corporate Structure in $1.1B Deal for External Manager
Royalty Pharma agreed to acquire its external manager, RP Management, in a $1.1 billion deal that it believes will pay for itself in the long-term as it aims to simplify its corporate structure.
Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference
Portfolio Receipts expected to be approximately $2,800 million, at the upper end of guidance rangeExciting development-stage pipeline with ...
What To Expect From JNJ Stock In 2025?
Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...
Even Trump Can’t Stop America’s Green Transition, Says Biden’s Top Climate Adviser
As he prepares to leave the White House, Ali Zaidi is sober about what’s coming—but says too much has already been built and ...
Sanofi: Underappreciated Powerhouse Primed For Long-Term Growth (Rating Upgrade)
Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...
The American Journal of Managed Care15h
The Future of Pharmacy: Trends, Threats, Transformations
The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...
Dragons’ Den fans spot moment Steven Bartlett gets ‘destroyed’ after spreading health misinformation
Dragons’ Den viewers have quipped Steven Bartlett was ‘destroyed’ after being slammed for sharing health misinformation. The entrepreneur and podcaster, 32, is the founder of the social media ...